Martin Siegemund

Company: Pieris Pharmaceuticals

Job title: Senior Scientist

Seminars:

Tumor-Targeted Antibody-Anticalin Bispecifics as Potent Costimulatory Molecules 4:00 pm

Novel costimulators facilitate the generation of multispecific protein formats addressing specific biological modalities Robust and highly selective Anticalin® proteins serving as agonists of costimulatory receptors like 4-1BB Mabcalin™ proteins leverage receptor engagement in immuno-oncology by rational combination with precision targetingRead more

day: Day One